INTRODUCTION
============

Dementia is a neurodegenerative disease caused by gradual loss of cortical neurons, and characterized by a progressive deterioration in memory, other cognitive functions, self-care, and personality \[[@b1-kjfm-17-0061]\]. According to a Korean epidemiologic survey of dementia conducted in 2012, the prevalence rate of dementia among persons aged \>65 years was 9.2%, and the number of persons with dementia was 540,755 (155,955 males and 384,800 females, which is expected to increase to 2,710,000 by 2050 \[[@b2-kjfm-17-0061]\].

The behavioral and psychological symptoms of dementia (BPSD) involve psychotic, affective, and behavioral elements. The symptoms, such as anxiety, agitation, nervousness, depression, elation, abnormal expression of feelings, emotional incontinence, delusion, or hallucination, can lead to rapid cognitive deterioration and functional impairment in patients, emotional and physical distress in family members and caregivers, and increased medical expenses \[[@b3-kjfm-17-0061]\].

Alzheimer disease (AD) is the most common cause of dementia in Korea. The pathogenesis of BPSD in AD patients has not been clearly delineated; however, emerging literature suggests that neurochemical, neuropathological, (e.g., cholinergic system dysfunction \[[@b4-kjfm-17-0061]\]), and genetic factors all contribute \[[@b5-kjfm-17-0061]\]. Thus, categorization of BPSD in clusters accounting for their natural course, prognosis, and treatment response may be useful in clinical practice.

In addition to the influence of dementia stage and subtype, patient factors, including age, gender, psychotropic medication use, combined neuropsychiatric symptoms such as depression or lack of disease insight, neurocognitive deficits, environmental factors including crowded housing conditions, and/or attitude of care staff, may be associated with the emergence of BPSD \[[@b6-kjfm-17-0061]\].

However, previous studies on the BPSD have yielded inconsistent findings. Moreover, most studies have been conducted in Western countries where no comprehensive study with a large patient sample size has been carried out.

In this study, the factors influencing BPSD in AD patients were examined using data from the Clinical Research of Dementia of South Korea (CREDOS) study.

METHODS
=======

1. Subjects and Study Design
----------------------------

The CREDOS study, a prospective, cohort study, was conducted at 56 hospitals in Korea from November 2005 to May 2012. Details of the CREDOS data have been previously published \[[@b7-kjfm-17-0061]\]. This study used data from 1,737 patients who were diagnosed with AD based on criteria from the NINCDS-ADRDA (National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association) after excluding Lewy body dementia, Parkinson disease, Huntington disease, and mild cognitive impairment.

Patients with serious diseases (uncontrollable diabetes, serious liver failure, arrhythmia, advanced kidney disease, and malignancy), serious hearing impairment or visual disturbance, mental illness, neurological disease from penetrated basal ganglia, and missing blood tests or psychological tests were excluded. Finally, 1,128 patients were examined in this study. Each patients was matched to their caregiver to obtain information regarding cognition, activities of daily living, demographic characteristics, BPSD, and other comorbidities.

Caregivers of patients were defined as those who met the following conditions: (1) those who were a patient's relative, (2) those who had close relationships with patients and spent time with them regularly, and (3) those who consented to be interviewed.

All study procedures were approved by the Institutional Review Board at relevant clinical centers (\#2005-02-008, ClinicalTrials.gov registration number: NCT01198093). Written informed consent was obtained from each participant.

2. Behavioral and Psychological Symptoms of Dementia Assessment
---------------------------------------------------------------

BPSD were examined by the patient caregivers using the Korean version of the Neuropsychiatric Inventory (K-NPI). The K-NPI measures 12 domains of behavioral and psychological symptoms, including delusion, hallucination, agitation/aggression, depression/dysphoria, anxiety, euphoria/elation, apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, night-time behavior, and appetite/eating changes. Caregivers were asked to describe the patient symptoms that had occurred during the previous 4 weeks. Caregivers were to describe the symptom frequency (scores of 1--4) and severity (scores of 1--3). Each item had scores ranging from 0 to 12 as calculated by multiplying frequency and severity \[[@b8-kjfm-17-0061]\]. The total score ranged from 0 to 144 after summing the scores for each item.

3. Neuropsychological Assessment
--------------------------------

The Seoul Neuropsychological Screening Battery (SNSB) is a comprehensive neuropsychological test that evaluates five cognitive domains: attention, memory, language, visuospatial function, and frontal/executive function. The dementia version of Seoul Neuropsychological Screening Battery (SNSB-D) was modified from the original SNSB to assess dementia patients \[[@b9-kjfm-17-0061]\]. The SNSB-D consists of the following tests: attention (score of 0--17), language and related function (score of 0--27), visuospatial ability (score of 0--36), memory (score of 0--150), and frontal/executive function (score of 0--70). Higher scores indicate more preserved function in all sub-domains.

4. Clinical Assessment
----------------------

The Korean version of Mini-Mental Status Examination (K-MMSE), Clinical Dementia Rating Sum of Box (CDR-SB), and Global Deterioration Scale (GDS) were administered. Depression was defined using the Geriatric Depression Scale consisting of 15 items.

The Barthel Index for Activities of Daily Living (Barthel-ADL) was used to evaluate the ability to accomplish basic ADLs. Scores for the Barthel-ADL range from 0 to 20. A higher score indicates greater independence \[[@b10-kjfm-17-0061]\]. In this study, the Seoul-Instrumental Activities of Daily Living (S-IADL) was also used to evaluate instrumental ADLs \[[@b11-kjfm-17-0061]\]. The SIADL was developed to evaluate patient social and instrumental ADLs. All items were measured based on a four-point scale ranging from 0 to 3, with scores ranging from 0 to 24. A lower score indicates a better ability to perform social and instrumental ADLs.

A medical history of hypertension, heart disease, diabetes, gastrointestinal disease, brain surgery, anemia, arthritis, epilepsy, neuropsychiatric disease, and carbon monoxide poisoning by doctor's diagnosis, and a family history of stroke and dementia were obtained. All participants underwent brain magnetic resonance imaging and routine laboratory tests including complete blood count, blood chemistry profiles, vitamin B12 and folate levels, syphilis serology, thyroid function, and lipid level. They were also assessed for the following variables: phone (user, non-user), smoking (current, former, and non-smoker), previous alcohol use (a lot, a little, or non-drinking), current alcohol drinking (drinker, non-drinker), occupation, education, and driving. Age, caregiver gender, and presence or absence of a caregiver in the home were assessed.

5. Statistical Analyses
-----------------------

To evaluate the association between the K-NPI and each variable evaluated at AD diagnosis, Spearman's rank correlation analysis was used for continuous variables. The Wilcoxon signed rank-sum test for two or fewer categorical variables or the Kruskal-Willis rank test for three or more categorical variables were used. Correlations with factors influencing the K-NPI were analyzed using median regression analysis. Two-tailed tests were conducted with statistical significance set at P\<0.05. STATA SE ver. 10.0 (Stata Corp., College Station, TX, USA) was used for all statistical analyses.

RESULTS
=======

[Table 1](#t1-kjfm-17-0061){ref-type="table"} presents the general patient characteristics. The mean patient age was 72.9 years. Males accounted for 37.8% of the patients. Patients who participated in this study had 8 years of education on average. Drinkers accounted for 21.3%, ex-smokers 20.7%, current smokers 9.1%, drivers 10.7%, and mobile phone users 58.1% of all patients. The average caregiver age was 53.3 years with 35.8% males.

[Table 2](#t2-kjfm-17-0061){ref-type="table"} presents the correlations between the clinical or demographic characteristics and the K-NPI score. When examining the correlations between demographic and health-related behavior and the K-NPI score, patients who did not use a mobile phone, who did not have a job at the time of the survey, and who had experienced drinking heavily in the past achieved higher K-NPI scores. The association between years of education and the K-NPI score was marginally significant.

The ADL and K-MMSE scores exhibited significant negative correlations with the K-NPI. The S-IADL, CDR-SB, and GDS scores were significantly positively correlated with the K-NPI score. There was a negative correlation between the SNSB-D and K-NPI scores, with lower SNSB-D scores correlated with higher K-NPI scores.

An abnormal level of free T4, anemia, gastrointestinal disease, and family history of stroke were correlated with the K-NPI scores. In addition, female and younger caregivers were associated with higher KNPI scores.

[Table 3](#t3-kjfm-17-0061){ref-type="table"} presents the results of a multivariate analysis after adjusting for age, education years, phone use, previous heavy drinking, and having an occupation in the past. The ADL score (P\<0.001), K-MMSE score (P=0.003), and caregiver age (P=0.005) were negatively associated with the K-NPI. For the SNSB-D items, memory (P=0.022) and frontal and executive function (P\<0.001) exhibited significant negative correlations. The significant negative associations between the K-NPI score and the SNSB-D items of attention, language, and visuospatial function were attenuated after adjusting for confounding factors. The S-IADL (P\<0.001), CDR-SB (P\<0.001), and GDS (P\<0.001) scores exhibited positive associations with the K-NPI score.

An abnormal free T4 level (P\<0.001), the presence of anemia (P\<0.001), and a family history of stroke (P=0.001), and the presence of a female caregiver (P=0.004) also had significant correlations with the K-NPI score.

DISCUSSION
==========

In this study, we comprehensively evaluated the correlation between the BPSD and demographic characteristics, health-related behavior, neuropsychological tests, blood tests, and caregiver characteristics of AD patients.

These results confirmed that BPSD in AD patients were related to various factors including patient factors and caregiver factors. In particular, patient dependency and AD severity had strong associations with BPSD. In addition, the presence of anemia; an abnormal free T4 level; a family history of stroke; and the presence of young, female caregivers were correlated with BPSD.

In previous studies measuring dementia severity using the MMSE score, a low MMSE score was correlated with the BPSD in AD patients \[[@b12-kjfm-17-0061]-[@b14-kjfm-17-0061]\]. Similarly, our study revealed that dementia severity exhibited significant correlations with the BPSD, although the mean MMSE score in our study was higher than that in previous studies (mean MMSE score: 20.09 in our study versus 17.8 \[[@b12-kjfm-17-0061]\] versus 16.9 \[[@b13-kjfm-17-0061]\] versus 13.4 \[[@b14-kjfm-17-0061]\]). Overall, the severity of dementia may be correlated with the emergence of BPSD.

Among the cognitive sub-domains, memory impairment was significantly correlated with the K-NPI score. There may be several reasons for the association of memory impairment and BPSD in AD patients. First, memory function has been demonstrated to be related to the anterior cingulate \[[@b15-kjfm-17-0061]\]. The anterior cingulate may be involved in the presentation of some BPSD \[[@b16-kjfm-17-0061]\]. Our results suggested that memory was correlated with the BPSD. However, there are few studies on the correlation between the SNSB-D score and the BPSD. Therefore, it is necessary to conduct further studies.

Second, the association between psychosis and impaired cognition including performance memory \[[@b17-kjfm-17-0061]\], semantic memory \[[@b18-kjfm-17-0061]\], executive function \[[@b18-kjfm-17-0061]\], short-term and delayed memory, executive functions, and information processing speed \[[@b19-kjfm-17-0061]\] can be explained by genes that impact the frontal cognitive system, including catechol-O-methyltransferase \[[@b20-kjfm-17-0061]\], frontal brain pathology, and/or frontal metabolic deficiencies, which can be confirmed with functional imaging studies \[[@b21-kjfm-17-0061]\].

A study investigating correlations between the Cumulative Illness Rating Scale and the NPI in dementia patients revealed that several NPI items had significant associations with medical illnesses including genitourinary and respiratory diseases \[[@b22-kjfm-17-0061]\]. Cerebrovascular diseases had significant associations with psychosis of AD, particularly delusion \[[@b23-kjfm-17-0061]\]. In our study, patients with anemia and abnormal free T4 levels obtained higher NPI scores. However, high blood pressure, which has been demonstrated to be a risk factor for cerebrovascular disease, was not significantly correlated with the K-NPI score, whereas family history of stroke was significantly correlated with the K-NPI score. Thus, further research is needed to examine these findings.

The association between thyroid function and AD has been inconsistent. Stern et al. \[[@b24-kjfm-17-0061]\] reported that thyroid stimulating hormone (TSH) and free T4 levels were not significantly associated with the BPSD in AD patients. However, a higher free T4 level was associated with atrophy of the hippocampus and amygdala on magnetic resonance imaging \[[@b25-kjfm-17-0061]\] or with greater numbers of neocortical neuritic plaques and neurofibrillary tangles \[[@b26-kjfm-17-0061]\]. Therefore, the free T4 level, rather than the TSH level, may be associated with BPSD.

A cohort study reported that a higher or lower hemoglobin level was related to AD and earlier decline in AD-related cognitive function \[[@b27-kjfm-17-0061]\]. However, few studies have investigated the correlations between anemia and the BPSD.

A recent study reported that diabetes was associated with progression from mild cognitive impairment to AD \[[@b28-kjfm-17-0061]\] and another study reported that diabetes was related to a decline in AD patient cognitive function \[[@b29-kjfm-17-0061]\]. In this study, diabetes was not significantly correlated with AD behavioral and psychological symptoms. We suggest that this was because the enrolled diabetes patients may have been well-controlled, or their diabetes history was obtained from a self-administered questionnaire, not from fasting glucose or hemoglobin A1C measurements. Thus, it is necessary to carry out further research on the relationships between diabetes and the BPSD.

The patient-caregiver relationship can have an effect on BPSD in AD patients \[[@b30-kjfm-17-0061]\]. Although we did not assess the patient-caregiver emotional relationship and communication, we found that the young caregivers were associated with higher K-NPI scores. This may be attributed to differences in the quality of care provided by caregivers due to experience, emotional relationships, or familiarity.

Additionally, in our study, caregiver age, gender, and family history of stroke were associated with the BPSD. These are meaningful as risk factors and these findings warrant further research in the future.

Our study has several strengths. First, we confirmed our hypothesis with a large national sample from 56 hospitals in Korea. There have been several studies on the factors influencing BPSD, but the results were inconsistent. However, those studies enrolled small populations. Second, a wide range of variables that were related to AD development or deterioration were evaluated according to patient and caregiver factors including demographics, health-related behavior, and clinical and neuropsychological tests. Our findings that more severe AD, lower frontal lobe function, anemia, and thyroid dysfunction were related to BPSD severity had been demonstrated in other studies; hence, we confirmed those results in data for large population.

The study also had some limitations. First, the findings cannot be generalized to other types of dementia patients, because this study was confined to AD patients. Indeed, the medications for AD and their effect, patient's mood, sleep, general nutritional status, care environment and quality, and communication between patients and caregivers may be more important risk factors for the BPSD. However, this study did not cover all possible risk factors such as medication history, including the use of cholinesterase inhibitors, or physical activity level, which were not surveyed in the CREDOS study. Additionally, blood test results were merely classified into normal or abnormal.

In conclusion, AD patients exhibited various risk factors for BPSD, including the inability to live an independent life and AD severity. We comprehensively examined many factors that were predicted to be associated with the BPSD. These findings suggest that a comprehensive strategy for the prevention and treatment of BPSD is important for AD patients.

No potential conflict of interest relevant to this article was reported.

###### 

Clinical and demographic characteristics of the subjects (N=1,128)

  Characteristic                                                        Value
  --------------------------------------------------------------------- -----------
  Demographic characteristics                                           
   Age (y)                                                              73.0±8.0
   Sex (male)                                                           37.8
   Education (y)                                                        8.2±5.1
   Drinking                                                             21.3
   Ex-smoker                                                            20.7
   Current smoker                                                       9.1
   Driving                                                              10.7
   Phone                                                                58.1
   Caregiver sex (male)                                                 35.8
   Caregiver age (y)                                                    53.3±14.7
  Clinical characteristics                                              
   Activities of daily living (total score=20)                          19.3±2.0
   Seoul-Instrumental Activities of Daily Living (total score=24)       16.3±9.4
   Korean version of the Neuropsychiatric Inventory (total score=144)   12.5±15.5
   Korean version of Mini-Mental Status Examination (total score=25)    20.1±4.4
   Clinical Dementia Rating Sum of Box (total score=18)                 4.8±2.6
   Global Deterioration Scale (total score=7)                           4.1±0.8
   Diabetes mellitus                                                    19.41
   Hypertension                                                         45.7
   Heart disease                                                        12.4

Values are presented as mean±standard deviation or %.

###### 

Correlations among the clinical and demographic characteristics of patients and the scores on the Korean version of the Neuropsychiatric Inventory

  Variable                                                                                               Statistics   P-value
  ------------------------------------------------------------------------------------------------------ ------------ ---------
  Demographics and health-related behavior                                                                            
   Age (y)^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                                0.019        0.517
   Gender (male/female)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                    -0.041       0.967
   Education (y)^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                          -0.057       0.057
   Phone (use/not use)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                     2.999        0.003
   Previous heavy drinking^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                 1.977        0.048
   Current alcohol drinking (drinker/non-drinker)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^          -1.100       0.271
   Smoking history (current smoker/ex-smoker/non-smoker)^[‡](#tfn3-kjfm-17-0061){ref-type="table-fn"}^   2.343        0.310
   Occupation_p (with/without)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                             0.136        0.892
   Occupation_c (with/without)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                             4.132        \<0.001
  Clinical assessment                                                                                                 
   Activities of daily living^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                             -0.257       \<0.001
   Seoul-Instrumental Activities of Daily Living^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^          0.401        \<0.001
   Korean version of Mini-Mental Status Examination^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^       -0.134       \<0.001
   Clinical Dementia Rating Sum of Box^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                    0.377        \<0.001
   Global Deterioration Scale^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                             0.296        \<0.001
  Neuropsychological test (Seoul Neuropsychological Screening Battery-dementia score)                                 
   Attention^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                              -0.091       0.002
   Language^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                               -0.087       0.004
   Visuospatial^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                           -0.068       0.022
   Memory^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                                 -0.112       \<0.001
   Frontal and executive^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                  -0.154       \<0.001
  Known medical history (with/without)                                                                                
   Diabetes mellitus^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                       -0.166       0.868
   Hypertension^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                            -0.684       0.494
   Heart disease^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                           -1.377       0.169
   Head trauma^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                             0.173        0.863
   Carbon monoxide poisoning^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                               -1.280       0.201
   Brain surgery^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                           -0.354       0.724
   Abnormal free thyroxine^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                 -2.284       0.022
   Abnormal thyroid stimulating hormone^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                    -0.205       0.838
   Anemia^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                                  -5.502       \<0.001
   Arthritis^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                               -1.762       0.078
   Epilepsy^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                                -1.315       0.188
   Gastrointestinal disease^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                -2.978       0.003
   Dyslipidemia^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                            -1.122       0.262
   Alcoholics^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                              -0.971       0.332
   Depression^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                              -1.136       0.256
   Previous neuropsychiatric history^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                       -0.621       0.534
   Stroke family history (with/without)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                    -3.414       \<0.001
   Dementia family history (with/without)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                  -0.143       0.886
  Caregiver                                                                                                           
   Age (y)^[\*](#tfn1-kjfm-17-0061){ref-type="table-fn"}^                                                -0.099       \<0.001
   Gender (male/female)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                    3.489        \<0.001
   Living (with/without)^[†](#tfn2-kjfm-17-0061){ref-type="table-fn"}^                                   -0.669       0.504

Occupation_p: patient who had an occupation in the past, Occupation_c: patient who has an occupation currently.

Continuous variables (spearman's rank correlation coefficient, rho).

Two or fewer categorical variables (Wilcoxon signed rank-sum, Z).

Three or more categorical variables (Kruskal-Willis rank test, X~3~^2^).

###### 

Median regression analysis for the factors associated with Korean version of the Neuropsychiatric Inventory

  Variable                                                                              Coefficient   Standard error   t-value   95% confidence interval   P-value
  ------------------------------------------------------------------------------------- ------------- ---------------- --------- ------------------------- ---------
  Clinical assessment                                                                                                                                      
   Activities of daily living                                                           -2.542        0.149            -17.06    -2.834 to -2.249          \<0.001
   Seoul-Instrumental Activities of Daily Living                                        0.490         0.028            17.55     0.435 to 0.545            \<0.001
   Korean version of Mini-Mental Status Examination                                     -0.294        0.098            -3.00     -0.486 to -0.102          0.003
   Clinical Dementia Rating Sum of Box                                                  1.841         0.151            12.22     1.546 to 2.137            \<0.001
   Global Deterioration Scale                                                           3.596         0.502            7.17      2.612 to 4.580            \<0.001
  Neuropsychological test (Seoul Neuropsychological Screening Battery-dementia score)                                                                      
   Attention                                                                            -0.378        0\. 195          -1.94     -0.759 to 0.004           0.053
   Language                                                                             -0.069        0.099            -0.69     -0.264 to 0.127           0.490
   Visuospatial                                                                         -0.038        0.046            -0.81     -0.129 to 0.054           0.418
   Memory                                                                               -0.064        0.028            -2.29     -0.119 to -0.009          0.022
   Frontal and executive                                                                -0.162        0.035            -4.58     -0.231 to -0.092          \<0.001
  Known medical history                                                                                                                                    
   Abnormal free T4                                                                     17.207        3.819            4.51      9.714 to 24.700           \<0.001
   Anemia                                                                               4.304         0.924            4.66      2.491 to 6.118            \<0.001
   Gastrointestinal disease                                                             2.75          1.492            1.84      -0.178 to 5.678           0.066
   Stroke family history                                                                2.9           0.902            3.22      1.130 to 4.670            0.001
  Caregiver                                                                                                                                                
   Age (y)                                                                              -0.082        0.029            -2.81     -0.140 to -0.025          0.005
   Gender (male/female)                                                                 -2.522        0.864            -2.92     -4.217 to -0.827          0.004
